Combination of encorafenib and cetuximab with or without alpelisib in patients with advanced BRAF-mutant colorectal cancer (BRAFm CRC): Phase 2 results Meeting Abstract
| Authors: | Tabernero, J.; van Geel, R.; Guren, T.; Yaeger, R.; Spreafico, A.; Faris, J.; Yoshino, T.; Yamada, Y.; Kim Tae, W.; Bendell, J.; Schuler, M.; Lenz, H. J.; Eskens, F.; Desai, J.; Hochster, H.; Avsar, E.; Demuth, T.; Sandor, V.; Elez, E.; Schellens, J. |
| Abstract Title: | Combination of encorafenib and cetuximab with or without alpelisib in patients with advanced BRAF-mutant colorectal cancer (BRAFm CRC): Phase 2 results |
| Meeting Title: | ESMO 18th World Congress on Gastrointestinal Cancer |
| Journal Title: | Annals of Oncology |
| Volume: | 27 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2016 Jun 29-Jul 2 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2016-06-01 |
| Start Page: | ii127 |
| End Page: | ii128 |
| Language: | English |
| ACCESSION: | WOS:000379756200408 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdw198.25 |
| Notes: | Meeting Abstract: O-026 -- Source: Wos |
